The future of pediatric oncology: Comprehensive review of causes, mortality, and treatment strategies

Pediatric oncology is confronting rising cancer rates among children, which poses a significant global health challenge. This review article delves into the multifaceted aspects of pediatric cancers, including their etiology, advanced diagnostic methods, and comprehensive treatment approaches. The article explores both genetic predispositions and environmental factors that contribute to the development of cancer in children. It underscores the importance of cutting-edge diagnostic tools such as next-generation sequencing and liquid biopsies. These technologies have revolutionized our understanding of cancer’s molecular basis, leading to more precise diagnoses and enabling personalized treatment regimens. In terms of treatment, the review discusses traditional methods like chemotherapy, radiation therapy, immunotherapy, target therapy, stem cell transplant and surgical interventions. It also sheds light on innovative therapies such as immunotherapy and targeted treatments that have shown promise in improving survival rates while minimizing adverse effects. The review also addresses the stark disparities in healthcare access and survival rates between developed and developing countries. It emphasizes the critical need for global efforts to provide equitable care to all pediatric cancer patients. Looking ahead, the article highlights the potential of personalized medicine to transform pediatric oncology. It also points to emerging therapies and international collaborations as key factors in advancing care and outcomes for young patients with cancer. This comprehensive review serves as a valuable resource for healthcare professionals, researchers, and policymakers. It provides a thorough analysis of current challenges in pediatric oncology and offers a forward-looking perspective on opportunities for future advancements.